RANCHO CORDOVA, Calif., Jan. 9 /PRNewswire/ -- Volcano Corporation announced today that Ronald A. Matricaria joined the Volcano Board of Directors and will act as the Chairman of the Compensation Committee.
Mr. Matricaria has had a highly successful career in the healthcare industry spanning nearly four decades. From 1993 to 2002, Mr. Matricaria was President and Chief Executive Officer and then Chairman of St Jude Medical Inc. He led the Company’s diversification strategy to become a broad-based cardiovascular device company, which today is a world market leader in cardiac surgery, cardiac rhythm management, and vascular closure products and services. Prior to joining St. Jude Medical, Mr. Matricaria spent 24 years at Eli Lilly and Company. His last position was as President of North American Operations and Executive Vice President of the pharmaceutical division. He also was President of Lilly International, as well as President of the medical device division, which was later spun off as Guidant Corporation.
Mr. Matricaria is currently a director of several other medical device companies, including Invitrogen, VistaCare, and Haemonetics Corporation where he is the Chairman. In addition, Mr. Matricaria has served on the boards of Home Depot, Cyberonics, and numerous other public companies in the healthcare sector.
Scott Huennekens, President and CEO of Volcano said, “Ron Matricaria brings a track record of proven success from a number of cardiovascular device companies. His expertise and experience will be a tremendous asset to Volcano as we continue to grow. Additionally, we are fortunate to have someone with his knowledge of both the pharmaceutical and medical device markets, as this will complement the strengths and experiences represented on our present Board. We are very excited that Ron has joined our Board and we look forward to his significant contributions.”
“Volcano Corporation has a product portfolio that could greatly improve the delivery of interventional procedures and how cardiac patients are treated. I am pleased to be part of this organization and look forward to contributing to the advancement of technology for diagnosing and treating cardiovascular disease. The vision of Volcano is very promising,” said Ron Matricaria.
About Volcano Corporation
Volcano Corp. is a privately held medical device company founded in 2001. With over 475 worldwide employees, Volcano is dedicated to providing technologies leading to optimal management of coronary artery and peripheral vascular disease. Volcano products include Intravascular Ultrasound (IVUS) systems and catheters, as well as physiology guide wires. With global distribution, Volcano is a leading provider of innovative therapy-enabling and therapy-guiding technologies to the interventional cardiology and peripheral vascular fields. For more information, please visit www.volcanocorp.com.
The development, release and timing of any features or functionality described for our products is subject to many factors both within and outside of our control and we retain sole discretion as to the specific nature and timing of market release of such features or functionality. Volcano makes no commitment, promise or legal obligation to deliver any future product or service that may be mentioned in this press release or in any other general communication.
Volcano Corporation
CONTACT: United States, Scott Huennekens, President & CEO,+1-916-638-8008, or fax, +1-916-638-8112; or Japan, Junichi Osawa,President & Managing Director, or Koji Osaka, General Manager,+81-3-5791-2616; or Europe & Middle East, Michel Lussier, Vice President,Europe, Africa, Middle-East, Volcano Europe SA/NV, + 32 475 80 00 97, orfax, + 32 2 679 10 72, all of Volcano Corporation
Web site: http://www.volcanocorp.com//
